Yakob Liawatidewi - Apr 13, 2023 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Signature
/s/ Eva Wen, by power of attorney
Stock symbol
AMPH
Transactions as of
Apr 13, 2023
Transactions value $
-$245,224
Form type
4
Date filed
4/14/2023, 05:50 PM
Previous filing
Apr 12, 2023
Next filing
Jun 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $233K +11.5K +16.61% $20.23 80.7K Apr 13, 2023 Direct
transaction AMPH Common Stock Sale -$205K -5K -6.2% $41.00 75.7K Apr 13, 2023 Direct F1
transaction AMPH Common Stock Sale -$273K -6.49K -8.58% $42.00 69.2K Apr 13, 2023 Direct F1
holding AMPH Common Stock 2.46K Apr 13, 2023 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -11.5K -67.65% $0.00 5.5K Apr 13, 2023 Common Stock 11.5K $20.23 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2022.
F2 The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
F3 Shares subject to the option vest in four equal annual installments beginning on March 15, 2020.